These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
278 related articles for article (PubMed ID: 38566909)
1. The role of interleukin-33 in organ fibrosis. Di Carmine S; Scott MM; McLean MH; McSorley HJ Discov Immunol; 2022; 1(1):kyac006. PubMed ID: 38566909 [TBL] [Abstract][Full Text] [Related]
2. IL-33/ST2 Axis in Organ Fibrosis. Kotsiou OS; Gourgoulianis KI; Zarogiannis SG Front Immunol; 2018; 9():2432. PubMed ID: 30405626 [TBL] [Abstract][Full Text] [Related]
3. Group 2 innate lymphoid cells contribute to IL-33-mediated alleviation of cardiac fibrosis. Chen WY; Wu YH; Tsai TH; Li RF; Lai AC; Li LC; Yang JL; Chang YJ Theranostics; 2021; 11(6):2594-2611. PubMed ID: 33456562 [No Abstract] [Full Text] [Related]
4. The Interleukin-33/ST2 Pathway Is Expressed in the Failing Human Heart and Associated with Pro-fibrotic Remodeling of the Myocardium. Tseng CCS; Huibers MMH; van Kuik J; de Weger RA; Vink A; de Jonge N J Cardiovasc Transl Res; 2018 Feb; 11(1):15-21. PubMed ID: 29285671 [TBL] [Abstract][Full Text] [Related]
5. IL-10 is not anti-fibrotic but pro-fibrotic in endometriosis: IL-10 treatment of endometriotic stromal cells in vitro promotes myofibroblast proliferation and collagen type I protein expression. Matsuzaki S; Pouly JL; Canis M Hum Reprod; 2023 Jan; 38(1):14-29. PubMed ID: 36413036 [TBL] [Abstract][Full Text] [Related]
6. Crosstalk between Interleukin-1 Receptor-Like 1 and Transforming Growth Factor-β Receptor Signaling Promotes Renal Fibrosis. Zhu X; Lu J; Rao J; Ru D; Gao M; Shi D; Cao K; Wen S; Dai C; Wang X; Mi W; Liu L; Zhou H Am J Pathol; 2023 Aug; 193(8):1029-1045. PubMed ID: 37236504 [TBL] [Abstract][Full Text] [Related]
7. Matrix regulation of idiopathic pulmonary fibrosis: the role of enzymes. Clarke DL; Carruthers AM; Mustelin T; Murray LA Fibrogenesis Tissue Repair; 2013 Nov; 6(1):20. PubMed ID: 24279676 [TBL] [Abstract][Full Text] [Related]
8. Role of the IL-33/ST2 Activation Pathway in the Development of the Hepatic Fibrosis Induced by Maggi L; Camelo GMA; Rocha IC; Pereira Alves W; Moreira JMP; Almeida Pereira T; Tafuri WL; Rabelo ÉML; Correa A; Ecco R; Negrão-Corrêa DA Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373379 [No Abstract] [Full Text] [Related]
9. Persistent activation of signal transducer and activator of transcription 3 via interleukin-6 trans-signaling is involved in fibrosis of endometriosis. Matsuzaki S; Pouly JL; Canis M Hum Reprod; 2022 Jun; 37(7):1489-1504. PubMed ID: 35551394 [TBL] [Abstract][Full Text] [Related]
10. Thymosin β4 and the anti-fibrotic switch. Kleinman HK; Kulik V; Goldstein AL Int Immunopharmacol; 2023 Feb; 115():109628. PubMed ID: 36580759 [TBL] [Abstract][Full Text] [Related]
11. TGF-β1 - A truly transforming growth factor in fibrosis and immunity. Lodyga M; Hinz B Semin Cell Dev Biol; 2020 May; 101():123-139. PubMed ID: 31879265 [TBL] [Abstract][Full Text] [Related]
12. The IL-33:ST2 axis is unlikely to play a central fibrogenic role in idiopathic pulmonary fibrosis. Stephenson KE; Porte J; Kelly A; Wallace WA; Huntington CE; Overed-Sayer CL; Cohen ES; Jenkins RG; John AE Respir Res; 2023 Mar; 24(1):89. PubMed ID: 36949463 [TBL] [Abstract][Full Text] [Related]
13. Betulin and Ofori M; Danquah CA; Asante J; Ativui S; Doe P; Abdul-Nasir Taribabu A; Nugbemado IN; Mensah AN Heliyon; 2023 Jun; 9(6):e16914. PubMed ID: 37346329 [TBL] [Abstract][Full Text] [Related]
14. IL-33 Promotes ST2-Dependent Fibroblast Maturation via P38 and TGF-β in a Mouse Model of Epidural Fibrosis. Wang H; Wu T; Hua F; Sun J; Bai Y; Wang W; Liu J; Zhang M Tissue Eng Regen Med; 2022 Jun; 19(3):577-588. PubMed ID: 35195855 [TBL] [Abstract][Full Text] [Related]
15. ACKR2 limits skin fibrosis and hair loss through IFN-β. Butenko S; Ben Jashar N; Sheffer T; Sabo E; Schif-Zuck S; Ariel A FASEB J; 2021 Oct; 35(10):e21917. PubMed ID: 34533865 [TBL] [Abstract][Full Text] [Related]
16. The immunomodulatory role of interleukin-35 in fibrotic diseases. Luo M; Peng H; Chen P; Zhou Y Expert Rev Clin Immunol; 2019 Apr; 15(4):431-439. PubMed ID: 30590954 [TBL] [Abstract][Full Text] [Related]
17. Smad3 as a mediator of the fibrotic response. Flanders KC Int J Exp Pathol; 2004 Apr; 85(2):47-64. PubMed ID: 15154911 [TBL] [Abstract][Full Text] [Related]
19. Targeting TGF-β Mediated SMAD Signaling for the Prevention of Fibrosis. Walton KL; Johnson KE; Harrison CA Front Pharmacol; 2017; 8():461. PubMed ID: 28769795 [TBL] [Abstract][Full Text] [Related]
20. Galectin-3 and IL-33/ST2 axis roles and interplay in diet-induced steatohepatitis. Pejnovic N; Jeftic I; Jovicic N; Arsenijevic N; Lukic ML World J Gastroenterol; 2016 Nov; 22(44):9706-9717. PubMed ID: 27956794 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]